Steele Glenn Jr Md Phd reported option exercise involving 12,000 derivative units of PTC THERAPEUTICS, INC. at $0.00 for $0 on Sep 30, 2026

Option exercise
Form 4 code M. Exercise or conversion of a derivative security exempt under Rule 16b-3.
Director
DIR
Filed Oct 2, 2026

Facts from the filing

Form 4 · Derivative, table II
Disclosed value
$0Shares × reported price
Shares traded
12,000Stock Option (Right to Buy)
Price per share
$0.00Reported price. Read footnotes for ranges.
% of reported position traded
UnavailableThis security and ownership context
Holdings after
0Direct
Trade date
Sep 30, 2026Option exercise
Filed
Oct 2, 2026, 5:20 PM ET2-day reporting delay
Accession
0001269131-26-000005Code M · Transaction 235467
How reported position traded is calculated

Not calculated for derivative securities.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Other trades in this filing

Trade dateActivitySharesPriceValueDetails
Sep 30, 2026Sell12,000$65.16−$781,920Trade 235466
Sep 30, 2026Option exercise12,000$11.23$134,760Trade 235465
3 transaction rows in this filing. Joint filers share the same rows.

PTCT price since this filing

Daily closing prices, with the filing date and available return windows. Return methodology
PTCT · Daily closing priceDaily price data is pending. The chart appears when valid daily closes are available.
Filing dateReturn windows appear as prices become available.
Pre-filing1mo ago +9.6%1w ago −1.8%1d ago +2.4%
Returns since7d +2%30d −5.5%90d180d1y

Footnotes in full

F1: This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on March 9, 2026 F2: Currently exercisable.